Do you feel comfortable using JAK inhibitors in patients with a strong family history of CAD, but no other risk factors?  

I would say it is a reasonable option to consider, especially if they have failed anti-TNF agents and if they do not have other cardiac risk factors. The studies which showed the highest risk used higher doses of JAK inhibitors, and those patients had other cardiac risk factors, so would suggest to...